SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
TWD 89.2
(-3.36%)
TWD 89.2
(-3.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -264.16 Million TWD | 36.65% |
| 2022 | -416.96 Million TWD | 10.28% |
| 2021 | -464.73 Million TWD | -89.55% |
| 2020 | -245.17 Million TWD | -530.81% |
| 2019 | 56.9 Million TWD | -66.76% |
| 2018 | 171.18 Million TWD | -40.57% |
| 2017 | 288.02 Million TWD | 199.47% |
| 2016 | -289.55 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -351.55 Million TWD | -11.47% |
| 2024 Q1 | -315.37 Million TWD | -19.38% |
| 2023 FY | -264.16 Million TWD | 36.65% |
| 2023 Q4 | -264.16 Million TWD | -10.31% |
| 2023 Q3 | -239.48 Million TWD | 36.14% |
| 2023 Q2 | -374.99 Million TWD | 15.31% |
| 2023 Q1 | -442.8 Million TWD | -6.2% |
| 2022 Q2 | -222.11 Million TWD | 32.01% |
| 2022 Q1 | -326.7 Million TWD | 30.25% |
| 2022 Q3 | -191.53 Million TWD | 13.77% |
| 2022 Q4 | -416.96 Million TWD | -117.7% |
| 2021 Q4 | -468.4 Million TWD | -316.64% |
| 2021 Q3 | -112.42 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Level Biotechnology Inc. | -453.9 Million TWD | 41.801% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -119.1% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -34.508% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 152.85% |
| GlycoNex Incorporation | -148.56 Million TWD | -77.811% |
| VBI | -25.31 Million TWD | -943.486% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 756.06% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 291.434% |
| Visgeneer Inc. | 31.28 Million TWD | 944.422% |
| Mycenax Biotech Inc. | 207 Million TWD | 227.612% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 61.186% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -96.771% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 142.503% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -358.165% |
| Enimmune corporation | -314.15 Million TWD | 15.912% |
| TaiRx, Inc. | -147.86 Million TWD | -78.651% |
| CHO Pharma, Inc. | -203.79 Million TWD | -29.627% |
| EirGenix Inc. | -4.58 Billion TWD | 94.242% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -211.656% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 318.554% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 91.791% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 16.776% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1233.311% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 930.485% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 620.479% |
| RBC Bioscience Corporation | 422.18 Million TWD | 162.572% |
| BiOptic Inc. | 12.59 Million TWD | 2197.911% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 72.028% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -160.301% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -59.932% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 183.897% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -242.881% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -0.604% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 963.919% |
| Neith Corporation | -150.31 Million TWD | -75.748% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -310.704% |
| NaviFUS Corp. | -123.12 Million TWD | -114.547% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 456.739% |
| Sinew Pharma Inc. | -160.34 Million TWD | -64.75% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -9.209% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 21.698% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 35.98% |
| AP Biosciences Inc | -196.52 Million TWD | -34.418% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 138.356% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -2209.775% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 68.161% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 119.462% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 36.326% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -26.193% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -83.625% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 20.08% |
| TCI GENE Inc. | -689.25 Million TWD | 61.673% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -122.106% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 79.822% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1389.699% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -159.32% |
| PharmaEngine, Inc. | -860.8 Million TWD | 69.312% |
| Savior Lifetec Corporation | -812.54 Million TWD | 67.489% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 11.934% |
| OBI Pharma, Inc. | -398.22 Million TWD | 33.663% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 27.708% |
| Acepodia, Inc. | -6.02 Billion TWD | 95.612% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 92.234% |